Works matching IS 0195668X AND DT 2020 AND VI 41 AND IP 42

Results: 21
    1
    2
    3

    Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.

    Published in:
    European Heart Journal, 2020, v. 41, n. 42, p. 4103, doi. 10.1093/eurheartj/ehz896
    By:
    • Pavasini, Rita;
    • Biscaglia, Simone;
    • Barbato, Emanuele;
    • Tebaldi, Matteo;
    • Dudek, Dariusz;
    • Escaned, Javier;
    • Casella, Gianni;
    • Santarelli, Andrea;
    • Guiducci, Vincenzo;
    • Gutierrez-Ibanes, Enrique;
    • Pasquale, Giuseppe Di;
    • Politi, Luigi;
    • Saglietto, Andrea;
    • D'Ascenzo, Fabrizio;
    • Campo, Gianluca
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry.

    Published in:
    European Heart Journal, 2020, v. 41, n. 42, p. 4127, doi. 10.1093/eurheartj/ehaa662
    By:
    • DeFilippis, Ersilia M;
    • Collins, Bradley L;
    • Singh, Avinainder;
    • Biery, David W;
    • Fatima, Amber;
    • Qamar, Arman;
    • Berman, Adam N;
    • Gupta, Ankur;
    • Cawley, Mary;
    • Wood, Malissa J;
    • Klein, Josh;
    • Hainer, Jon;
    • Gulati, Martha;
    • Taqueti, Viviany R;
    • Carli, Marcelo F Di;
    • Nasir, Khurram;
    • Bhatt, Deepak L;
    • Blankstein, Ron
    Publication type:
    Article
    12
    13

    Rheumatic heart disease and COVID-19.

    Published in:
    European Heart Journal, 2020, v. 41, n. 42, p. 4085, doi. 10.1093/eurheartj/ehaa660
    By:
    • Beaton, Andrea;
    • Zühlke, Liesl;
    • Mwangi, Jeremiah;
    • Taubert, Kathryn A
    Publication type:
    Article
    14

    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).

    Published in:
    European Heart Journal, 2020, v. 41, n. 42, p. 4092, doi. 10.1093/eurheartj/ehaa659
    By:
    • Bouabdallaoui, Nadia;
    • Tardif, Jean-Claude;
    • Waters, David D;
    • Pinto, Fausto J;
    • Maggioni, Aldo P;
    • Diaz, Rafael;
    • Berry, Colin;
    • Koenig, Wolfgang;
    • Lopez-Sendon, Jose;
    • Gamra, Habib;
    • Kiwan, Ghassan S;
    • Blondeau, Lucie;
    • Orfanos, Andreas;
    • Ibrahim, Reda;
    • Grégoire, Jean C;
    • Dubé, Marie-Pierre;
    • Samuel, Michelle;
    • Morel, Olivier;
    • Lim, Pascal;
    • Bertrand, Olivier F
    Publication type:
    Article
    15
    16
    17
    18

    Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.

    Published in:
    European Heart Journal, 2020, v. 41, n. 42, p. 4114, doi. 10.1093/eurheartj/ehaa498
    By:
    • Tuñón, José;
    • Steg, Philippe Gabriel;
    • Bhatt, Deepak L;
    • Bittner, Vera A;
    • Díaz, Rafael;
    • Goodman, Shaun G;
    • Jukema, J Wouter;
    • Kim, Yong-Un;
    • Li, Qian H;
    • Mueller, Christian;
    • Parkhomenko, Alexander;
    • Pordy, Robert;
    • Sritara, Piyamitr;
    • Szarek, Michael;
    • White, Harvey D;
    • Zeiher, Andreas M;
    • Schwartz, Gregory G;
    • Investigators, for the ODYSSEY OUTCOMES
    Publication type:
    Article
    19
    20
    21